Literature DB >> 8382417

Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors.

L Cárdenas1, J D Clements.   

Abstract

The use of attenuated strains of Salmonella as vaccine vectors frequently involves the introduction of heterologous antigens on recombinant plasmids. To overcome the problem of plasmid instability, we have integrated the gene that codes for a potential immunogen into the chromosome of a galE mutant of Salmonella typhimurium. Comparative in vitro and in vivo studies were conducted between the strain carrying the gene chromosomally integrated and an isogenic strain carrying the same gene on a multicopy plasmid. Levels of expression of the foreign antigen were significantly lower when the antigen was expressed from the chromosome than when it was expressed from the plasmid. The in vivo maintenance of the genes coding for antigen expression was determined on organisms recovered from spleen, liver and Peyer's patches of orally inoculated mice. By 24 h postinoculation, the majority of tissue isolates from the plasmid-containing strain had lost the plasmid and the ability to synthesize the antigen. By contrast, 100% of the recovered cointegrate isolates retained the ability to express the antigen throughout the 21 days of the experiment. Significantly, humoral and mucosal antibody levels against the antigen were greater when the antigen was expressed from the plasmid stabilized by the presence of the antibiotic than when the antigen was expressed from the chromosome. These observations indicate that the most important event for the development of an immune response against a foreign antigen delivered by these vectors may be the initial amount of antigen that primes the gut-associated lymphoid tissue and not persistence of the vector in tissues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382417     DOI: 10.1016/0264-410x(93)90007-k

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection.

Authors:  James E Galen; Jin Yuan Wang; Jose A Carrasco; Scott A Lloyd; Gabriela Mellado-Sanchez; Jovita Diaz-McNair; Olga Franco; Amanda D Buskirk; James P Nataro; Marcela F Pasetti
Journal:  Infect Immun       Date:  2014-10-20       Impact factor: 3.441

2.  Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses.

Authors:  D Bumann
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

3.  Construction of a tetR-integrated Salmonella enterica serovar Typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human Vaccine production.

Authors:  Feng Qian; Weiqing Pan
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Auxotrophs of Plasmodium falciparum dependent on p-aminobenzoic acid for growth.

Authors:  G A McConkey; I Ittarat; S R Meshnick; T F McCutchan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

5.  Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity.

Authors:  E L Hohmann; C A Oletta; W P Loomis; S I Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  Systemic and mucosal immune responses in mice orally immunized with avirulent Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin.

Authors:  D M Dusek; A Progulske-Fox; T A Brown
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  Construction and vaccine potential of acapsular mutants of Erysipelothrix rhusiopathiae: use of excision of Tn916 to inactivate a target gene.

Authors:  Y Shimoji; Y Mori; T Sekizaki; T Shibahara; Y Yokomizo
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

Review 8.  Salmonella enterica serovar Typhi live vector vaccines finally come of age.

Authors:  James E Galen; Marcela F Pasetti; Sharon Tennant; Patricia Ruiz-Olvera; Marcelo B Sztein; Myron M Levine
Journal:  Immunol Cell Biol       Date:  2009-05-05       Impact factor: 5.126

9.  A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae.

Authors:  A R Nayak; S A Tinge; R C Tart; L S McDaniel; D E Briles; R Curtiss
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

10.  Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans.

Authors:  S Khan; S Chatfield; R Stratford; J Bedwell; M Bentley; S Sulsh; R Giemza; S Smith; E Bongard; C A Cosgrove; J Johnson; G Dougan; G E Griffin; J Makin; D J M Lewis
Journal:  Vaccine       Date:  2007-03-21       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.